Posted 13 July, 2023
60 DEGREES PHARMACEUTICALS, INC. IPO completed
IPO completed detected for ticker Nasdaq:SXTP in a 424B4 filed on 13 July, 2023.
This is a firm commitment initial public offering of 1,415,095 units (each, a "Unit," collectively, the "Units") of 60 Degrees Pharmaceuticals, Inc. (the "Company," "we," "us" or "our").
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of 60 DEGREES PHARMACEUTICALS, INC.
Health Care/Life Sciences • Pharmaceuticals
60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.Market Cap
$3.21M
View Company Details
$3.21M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.